The most prevalent factors employers take into consideration for GLP-1 drug coverage for obesity care include: Obesity as a risk factor for chronic conditions and associated costs67% Drug shortages47% Impact/effectiveness of cost-control mechanisms47% Existing coverage through government programs40% Long-term costs33% Patient and prescriber demand33%
Blundell, J., Finlayson, G., Axelsen, M., Flint, A., Gibbons, C., Kvist, T., & Hjerpsted, J
Trocchio LL et al
For patients, the practical takeaway is straightforward: if your inflammation is closely tied to insulin resistance, central weight gain, fatty liver, or metabolic syndrome, a GLP-1 medication may help
In May 2024, Nestl introduced Vital Pursuit, a line of foods designed to be a companion to GLP-1 users, and plant-based frozen meal delivery service Daily Harvest has taken a similar approach
Genera such as Inocybe , Psilocybe , and Amanita produce various indole alkaloids, and preliminary research suggests that some may modulate glucose homeostasis, although further investigation is warranted